ArticleAnesthesia and analgesia2014

Enhancement of α5-containing γ-aminobutyric acid type A receptors by the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6) is abolished by the β3(N265M) mutation.

Paul M Burkat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.